论文部分内容阅读
通过对61例慢性肾炎、21例狼疮性肾炎、7例非肾炎性肾脏病变、5例肾移植、39例肾外其它系统疾病和31例健康成人的尿纤维蛋白(原)降解产物(FDP)测定,初步认为尿FDP测定对鉴定肾脏病性质有一定帮助,在排除其它脏器有明显纤溶现象时,可认为尿FDP主要来自肾本身疾病,而在肾脏病中,估计病理表现主要为炎症者尤易出现阳性;FDP阳性者,其肾功能损害者多;FDP与肾炎活动,特别是免疫反应的持续进行有关;单用尿FDP测定不足以监护肾移植排斥反应。
A total of 61 cases of chronic glomerulonephritis, 21 cases of lupus nephritis, 7 cases of non-nephritic nephropathy, 5 cases of renal transplantation, 39 cases of other renal diseases and 31 cases of healthy adult urinary fibrin degradation products (FDP) Determination, initially that the determination of urinary FDP on the identification of kidney disease have some help to identify the nature of the other organs in the clear fibrinolytic phenomenon, the urine FDP can be considered mainly from the kidney itself disease, and in kidney disease, the pathological findings are mainly inflammation Especially prone to positive; FDP-positive, renal impairment; FDP and nephritis activities, especially the ongoing immune response; single urinary FDP determination is not enough to monitor renal allograft rejection.